Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage

Molecular and Cellular Biology

Volumn 18, Issue 5, 1998, Pages 3089-3100

  Paulson, Thomas G ^a,b,d   Almasan, Alexandru ^c   Brody, Linnea L ^d   Wahl, Geoffrey M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; DNA STRAND BREAKAGE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0031893222     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.5.3089     Document Type: Article

References (85)

1. Almasan, A., S. P. Linke, T. G. Paulson, L. Huang, and G. M. Wahl. 1995. Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer Metas. Rev. 14:59-73.
2. Almasan, A., Y. Yin, R. Kelly, E. Lee, A. Bradley, W. Li, J. Bertino, and G. Wahl. 1995. pRb deficiency leads to inappropriate entry into S-phase, activation of E2F responsive genes and apoptosis. Proc. Natl. Acad. Sci. USA 92:5436-5440.
3. Anderson, M. J., C. L. Fasching, H. J. Xu, W. F. Benedict, and E. J. Stanbridge. 1994. Chromosome 13 transfer provides evidence for regulation of RB1 protein expression. Genes Chromosomes Cancer 9:251-260.
4. Andrulis, I. L., R. Argonza, and A. E. Cairney. 1990. Molecular and genetic characterization of human cell lines resistant to L-asparaginase and albizziin. Somat. Cell Mol. Genet. 16:59-65.
5. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith and K. Struhl. 1994. One-dimensional gel electrophoresis of proteins, 10.2. In K. Jannsen (ed.), Current protocols in molecular biology. Wiley-Interscience, New York, N.Y.
6. Ayusawa, D., K. Shimizu, H. Koyama, K. Takeishi, and T. Seno. 1983. Accumulation of DNA strand breaks during thymineless death in thymidylate synthase-negative mutants of mouse FM3A cells. J. Biol. Chem. 258: 12448-12454.
7. Benner, S. E., G. M. Wahl, and H. D. Von. 1991. Double minute chromosomes and homogeneously staining regions in tumors taken directly from patients versus in human tumor cell lines. Anticancer Drugs 2:11-25.
8. Boveri, T. (trans.) 1929. The origin of malignant tumours. Williams and Wilkins, Baltimore, Md.
9. Brown, P. C., T. D. Tlsty, and R. T. Schimke. 1983. Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea. Mol. Cell. Biol. 3:1097-1107.
10. Chen, C., I. Hall, T. Lansing, T. Gilmer, and M. Kastan. 1996. Separate pathways for p53 induction by ionizing radiation and N-(Phosphonoacetyl)-L aspartate. Cancer Res. 56:3659-3662.
11. Chen, T. R. 1977. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res. 104:255-262.
12. Chen, Y., B. Goz, and L. Kirkman. 1993. An analysis of vincristine-resistance in BHK cells pretreated with 1-beta-D-arabinofuranosylcytosine. Anticancer Res. 13:249-255.
13. Coquelle, A., E. Pipiras, F. Toledo, G. Buttin, and M. Debatisse. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
14. Cowell, J. K., and O. J. Miller. 1983. Occurrence and evolution of homogeneously staining regions may be due to breakage-fusion-bridge cycles following telomere loss. Chromosoma 88:216-221.
15. Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and B. J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353-6.
16. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
17. Denko, N., J. Stringer, M. Wani, and P. Stambrook. 1995. Mitotic and post mitotic consequences of genomic instability induced by oncogenic Ha-ras. Somat. Cell Mol. Genet. 21:241-253.
18. Denko, N. C., A. J. Giaccia, J. R. Stringer, and P. J. Stambrook. 1994. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc. Natl. Acad. Sci. USA 91:5124-5128.
19. de Vries, J. E., F. H. Kornips, P. Marx, F. T. Bosman, J. P. Geraedts, and J. ten Kate. 1993. Transfected c-Ha-ras oncogene enhances karyotypic instability and integrates predominantly in aberrant chromosomes. Cancer Genet. Cytogenet. 67:35-43.
20. Di Leonardo, A., P. Cavolina, and A. Maddalena. 1993. DNA topoisomerase II inhibition and gene amplification in V79/B7 cells. Mutat. Res. 301:177-182.
21. Di Leonardo, A., S. H. Khan, S. P. Linke, V. Greco, G. Seidita, and G. M. Wahl. 1997. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57:1013-1019.
22. Di Leonardo, A., S. P. Linke, K. Clarkin, and G. M. Wahl. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:2540-2551.
23. Di Leonardo, A., S. P. Linke, Y. Yin, and G. M. Wahl. 1993. Cell cycle regulation of gene amplification. Cold Spring Harbor Symp. Quant. Biol. 58:655-667.
24. Flintoff, W. F., S. V. Davidson, and L. Siminovitch. 1976. Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells. Somat. Cell Genet. 2:245-261.
25. Frei, E., A. Rosowsky, J. E. Wright, C. A. Cucchi, J. A. Lippke, T. J. Ervin, J. Jolivet, and W. A. Haseltine. 1984. Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture. Proc. Natl. Acad. Sci. USA 81:2873-2877.
26. Fukasawa, K., and G. F. Vande Woude. 1997. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol. Cell. Biol. 17:506-518.
27. Greenblatt, M. S., W. P. Bennett, M. Hollstein, and C. C. Harris. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-4878.
28. Hahn, P. J. 1993. Molecular biology of double-minute chromosomes. Bioessays 15:477-484.
29. Hartwell, L. H., and M. B. Kastan. 1994. Cell cycle control and cancer. Science 266:1821-1828.
30. Hill, A., and R. Schimke. 1985. Increased gene amplification in L5178Y mouse lymphoma cells with hydroxyurea-induced chromosomal aberrations. Cancer Res. 45:5050-5057.
31. Huang, L.-C., K. C. Clarkin, and G. M. Wahl. 1996. Sensitivity and selectivity of the p53-mediated DNA damage sensor. Proc. Natl. Acad. Sci. USA 93:4827-4832.
32. Hundley, J. E., S. K. Koester, D. A. Troyer, S. G. Hilsenbeck, M. A. Subler, and J. J. Windle. 1997. Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol. Cell. Biol. 17:723-731.
33. Johnson, B. E., J. Battey, I. Linnoila, K. L. Becker, R. W. Makuch, R. H. Snider, D. N. Carney, and J. D. Minna. 1986. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. J. Clin. Invest. 78:525-32.
34. Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352.
35. Johnston, R., S. Beverley, and R. Schimke. 1983. Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting. Proc. Natl. Acad. Sci. USA 80:3711-3715.
36. Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587-597.
37. Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491-7495.
38. Kufe, D. W., J. D. Griffin, and D. R. Spriggs. 1985. Cellular and clinical pharmacology of low-dose ara-C. Semin. Oncol. 2(Suppl. 3):200-207.
39. Kuo, M. T., R. C. Vyas, L. X. Jiang, and W. N. Hittelman. 1994. Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol. Cell. Biol. 14:5202-5211.
40. Labrecque, S., and G. J. Matlashewski. 1995. Viability of wild type p53-containing and p53-deficient tumor cells following anticancer treatment: the use of human papillomavirus E6 to target p53. Oncogene 11:387-392.
41. Lee, J. M., and A. Bernstein. 1995. Apoptosis, cancer and the p53 tumour suppressor gene. Cancer Metastasis Rev. 14:149-161.
42. Li, C. Y., H. Nagasawa, W. K. Dahlberg, and J. B. Little. 1995. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. Oncogene 11:1885-1892.
43. Li, J. C., and E. Kaminskas. 1984. Accumulation of DNA strand breaks and methotrexate cytotoxicity. Proc. Natl. Acad. Sci. USA 81:5694-5698.
44. Li, W., J. Fan, D. Hochhauser, D. Banerjee, Z. Zielinski, A. Almasan, Y. Yin, R. Kelly, G. M. Wahl and J. R. Bertino. 1995. Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc. Natl. Acad. Sci. USA 92:10436-10440.
45. Linke, S. P., K. C. Clarkin, L. A. Di, A. Tsou, and G. M. Wahl. 1996. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:934-947.
46. Little, J. B., H. Nagasawa, P. C. Keng, Y. Yu, and C. Y. Li. 1995. Absence of radiation-induced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. Biol. Chem. 270:11033-11036.
47. Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tisty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
48. Ma, C., S. Martin, B. Trask, and J. L. Hamlin. 1993. Sister chromatid fusion initiates amplification of the dihydrofolate reductase gene in Chinese hamster cells. Genes Dev. 7:605-620.
49. Marder, B. A., and W. F. Morgan. 1993. Delayed chromosomal instability induced by DNA damage. Mol. Cell. Biol. 13:6667-6677.
50. McClintock, B. 1984. The significance of responses of the genome to challenge. Science 226:792-801.
51. Moran, R. G., M. Mulkins, and C. Heidelberger. 1979. Role of thymidylate synthetase activity in development of methotrexate cytotoxicity. Proc. Natl. Acad. Sci. USA 76:5924-5928.
52. Moyer, J. D., P. A. Smith, E. J. Levy, and R. E. Handschumacher. 1982. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells. Cancer Res. 42:4525-4531.
53. Nagasawa, H., C. Y. Li, C. G. Maki, A. C. Imrich, and J. B. Little. 1995. Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. Cancer Res. 55:1842-1846.
54. Nelson, W. G., and M. B. Kastan. 1994. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1815-1823.
55. Nelson, W. G., and M. B. Kastan. 1994. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1815-1823.
56. Paulovich, A. G., D. P. Toczyski, and L. H. Hartwell. 1997. When checkpoints fail. Cell 88:315-321.
57. Poupon, M. F., K. A. Smith, O. B. Chernova, C. Gilbert, and G. R. Stark. 1996. Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles. Mol. Biol. Cell 7:345-354.
58. Rasheed, S. 1974. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33:1027-1033.
59. Ruiz, J. C., and G. M. Wahl. 1990. Chromosomal destabilization during gene amplification. Mol. Cell. Biol. 10:3056-3066.
60. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
61. Schimke, R. T. 1988. Gene amplification in cultured cells. J. Biol. Chem. 263:5989-5992.
62. Schimke, R. T. 1992. Gene amplification; what are we learning? Mutat. Res. 276:145-149.
63. Seeger, K. C., G. M. Brodeur, H. Sather, A. Dalton, S. E. Siegel, K. Y. Wong, and D. Hammond. 1985. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313:1111-1116.
64. Sharma, R. C., and R. T. Schimke. 1989. Enhancement of the frequency of methotrexate resistance by G-radiation in Chinese hamster ovary and mouse 3T6 cells. Cancer Res. 49:3861-3866.
65. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
66. Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. Press. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
67. Smith, K. A., M. L. Agarwal, M. V. Chernov, O. B. Chernova, Y. Deguchi, Y. Ishizaka, T. E. Patterson, M. F. Poupon, and G. R. Stark. 1995. Regulation and mechanisms of gene amplification. Philos. Trans. R. Soc. London B 347:49-56.
68. Smith, K. A., O. B. Chernova, R. P. Groves, M. B. Stark, J. L. Martinez, J. N. Davidson, J. M. Trent, T. E. Patterson, A. Agarwal, P. Duncan, M. L. Agarwal, and G. R. Stark. 1997. Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged. Proc. Natl. Acad. Sci. USA 94:1816-1821.
69. Smith, K. A., M. B. Stark, P. A. Gorman, and G. R. Stark. 1992. Fusions near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells. Proc. Natl. Acad. Sci. USA 89:5427-5431.
70. Sullivan, N. F., R. W. Sweet, M. Rosenberg, and J. R. Feramisco. 1986. Microinjection of the ras oncogene protein into nonestablished rat embryo fibroblasts. Cancer Res. 6427-6432
71. Swyryd, E. A., S. S. Seaver, and G. R. Stark. 1974. N-(Phosphonacetyl)-L-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture. J. Biol. Chem. 249:6945-6950.
72. Tlsty, T., P. C. Brown, R. Johnston, and R. T. Schimke. 1982. Enhanced frequency of generation of methotrexate resistance and gene amplification in cultured mouse and hamster cell lines, p. 231-238. In R. T. Schimke (ed.), Gene amplification. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
73. Tlsty, T. D. 1990. Normal diploid human and rodent cells lack a detectable 0frequency of gene amplification. Proc. Natl. Acad. Sci. USA 87:3132-3136:
74. Tlsty, T. D., B. H. Margolin and K. Lum. 1989. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis. Proc. Natl. Acad. Sci. USA 86:9441-9445.
75. Varshavsky, A. 1981. Phorbol ester dramatically increases incidence of methotrexate-resistant mouse cells: possible mechanisms and relevance to tumor promotion. Cell 25:561-572.
76. Wahl, G., P. Gaudray, S. Carroll, and N. Proctor. 1986. Is gene amplification inducible?, p. 71-98. In R. Dulbecco, V. De Vita, L. Santi, and L. Zardi (ed.), Cancer frontiers, proceedings of the Second International Conference on Progress in Cancer Research. Humana Press, Totowa, N.J.
77. Werness, B. A., A. J. Levine, and P. M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
78. Wettergren, Y., A. Kullberg, and G. Levan. 1994. Drug-specific rearrangements of chromosome 12 in hydroxyurea-resistant mouse SEWA cells: support for chromosomal breakage model of gene amplification. Somat. Cell Mol. Genet. 20:267-285.
79. White, A. E., E. M. Livanos, and T. D. Tlsty. 1994. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8:666-677.
80. Windle, B., B. W. Draper, Y. X. Yin, S. O'Gorman and G. M. Wahl. 1991. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev. 5:160-174.
81. Windle, B. E., and G. M. Wahl. 1992. Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. Mutat. Res. 276:199-224.
82. Wright, J. A., H. S. Smith, F. M. Watt, M. C. Hancock, D. L. Hudson, and G. R. Stark. 1990. DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. USA 87:1791-1795.
83. Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606.
84. Yang, J. K., J. N. Masters, and G. Attardi. 1984. Human dihydrofolate reductase gene organization. Extensive conservation of the G + C-rich 5′ non-coding sequence and strong intron size divergence from homologous mammalian genes. J. Mol. Biol. 176:169-187.
85. Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.